A pilot clinical study suggests that E6 is an appropriate biomarker for diagnosis of cervical pre-cancer and cancer in a novel oncoprotein-based rapid diagnostic assay for cervical pre-cancer and cancer. Presented at: International Papillomavirus Conference 2009, May 8, 2009; Malmo, Sweden.
E6 Based Rapid Diagnostic Test for Cervical Pre-Cancer and Cancer (poster)
405.1 KB PDF
Hard copies are not available.